Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Operating Expenses | 13,782 | 14,905 | 0 | 0 |
| Operating Income | -13,782 | -14,905 | N/A | N/A |
| Interest Expense | 30 | 2,077 | 0 | 0 |
| Other Income | -30,031 | -2 | 0 | 0 |
| Pre-tax Income | -43,843 | -16,984 | 0 | 0 |
| Net Income Continuous | -43,843 | -16,984 | N/A | N/A |
| Minority Interests | -3,336 | -4,350 | N/A | N/A |
| Net Income | $-40,507 | $-12,634 | $N/A | $N/A |
| EPS Basic Total Ops | -7.33 | -2.13 | N/A | N/A |
| EPS Basic Continuous Ops | -7.93 | -2.87 | N/A | N/A |
| EPS Diluted Total Ops | -7.33 | -2.13 | N/A | N/A |
| EPS Diluted Continuous Ops | -7.93 | -2.87 | N/A | N/A |
| EBITDA(a) | $-13,627 | $-14,905 | $N/A | $N/A |